Markovian negentropies in bioinformatics. 1. A picture of footprints after the interaction of the HIV-1 Psi-RNA packaging region with drugs.
BACKGROUND
Many experts worldwide have highlighted the potential of RNA molecules as drug targets for the chemotherapeutic treatment of a range of diseases. In particular, the molecular pockets of RNA in the HIV-1 packaging region have been postulated as promising sites for antiviral action. The discovery of simpler methods to accurately represent drug-RNA interactions could therefore become an interesting and rapid way to generate models that are complementary to docking-based systems.


RESULTS
The entropies of a vibrational Markov chain have been introduced here as physically meaningful descriptors for the local drug-nucleic acid complexes. A study of the interaction of the antibiotic Paromomycin with the packaging region of the RNA present in type-1 HIV has been carried out as an illustrative example of this approach. A linear discriminant function gave rise to excellent discrimination among 80.13% of interacting/non-interacting sites. More specifically, the model classified 36/45 nucleotides (80.0%) that interacted with paromomycin and, in addition, 85/106 (80.2%) footprinted (non-interacting) sites from the RNA viral sequence were recognized. The model showed a high Matthews' regression coefficient (C = 0.64). The Jackknife method was also used to assess the stability and predictability of the model by leaving out adenines, C, G, or U. Matthews' coefficients and overall accuracies for these approaches were between 0.55 and 0.68 and 75.8 and 82.7, respectively. On the other hand, a linear regression model predicted the local binding affinity constants between a specific nucleotide and the aforementioned antibiotic (R2 = 0.83,Q2 = 0.825). These kinds of models may play an important role either in the discovery of new anti-HIV compounds or in the elucidation of their mode of action.


BACKGROUND
On request from the corresponding author (humbertogd@cbq.uclv.edu.cu or humbertogd@navegalia.com).
Chemical Bioactives Center, Central University of Las Villas 54830, Cuba. humbertogd@vodafone.es
Humberto González
HG
Díaz
Ronal Ramos
RR
de Armas
Reinaldo
R
Molina
D001665:Binding Sites; D019295:Computational Biology / Q000379:methods; D003198:Computer Simulation; D018983:DNA Footprinting / Q000379:methods*; D015195:Drug Design; D019277:Entropy; D015497:HIV-1 / Q000737:chemistry*; D006801:Humans; D046911:Macromolecular Substances; D008390:Markov Chains; D008956:Models, Chemical; D008958:Models, Molecular; D015233:Models, Statistical; D010303:Paromomycin / Q000737:chemistry*; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D012367:RNA, Viral / Q000737:chemistry*; D017423:Sequence Analysis, RNA / Q000379:methods*
D046911:Macromolecular Substances; D004364:Pharmaceutical Preparations; D012367:RNA, Viral; D010303:Paromomycin